TGFB2 and diffuse intrinsic pontine glioma: The observed poor prognosis of newly diagnosed TGFB2high DIPG patients, as reported here, supports the notion that further exploration of the clinical potential of TGFB2-targeting RNAi therapeutics in TGFB2high DIPG patients is warranted.